A detailed history of Mairs & Power Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Mairs & Power Inc holds 2,696,796 shares of TECH stock, worth $197 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares
2,696,796
Previous 2,740,392 1.59%
Holding current value
$197 Million
Previous $196 Million 9.75%
% of portfolio
2.05%
Previous 1.91%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $3.09 Million - $3.59 Million
-43,596 Reduced 1.59%
2,696,796 $216 Million
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $13.6 Million - $18.4 Million
-218,965 Reduced 7.4%
2,740,392 $196 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $7.93 Million - $9.26 Million
-120,126 Reduced 3.9%
2,959,357 $208 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $1.37 Million - $2.03 Million
25,903 Added 0.85%
3,079,483 $238 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $409,036 - $541,706
-6,058 Reduced 0.2%
3,053,580 $208 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $2.48 Million - $2.89 Million
33,660 Added 1.11%
3,059,638 $250 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $15.4 Million - $18.6 Million
214,948 Added 7.65%
3,025,978 $224 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $172 Million - $753 Million
2,137,410 Added 317.3%
2,811,030 $233 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $5 Million - $6.93 Million
17,690 Added 2.7%
673,620 $191 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $655,665 - $913,688
-2,032 Reduced 0.31%
655,930 $227 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $1.47 Million - $2.02 Million
4,147 Added 0.63%
657,962 $285 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $4.02 Million - $4.63 Million
-8,819 Reduced 1.33%
653,815 $338 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $29.5 Million - $35.7 Million
-66,202 Reduced 9.08%
662,634 $321 Million
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $16 Million - $18.6 Million
-41,199 Reduced 5.35%
728,836 $328 Million
Q1 2021

May 14, 2021

SELL
$314.62 - $411.0 $24.6 Million - $32.1 Million
-78,046 Reduced 9.2%
770,035 $294 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $1.8 Million - $2.35 Million
-7,302 Reduced 0.85%
848,081 $269 Million
Q3 2020

Nov 16, 2020

SELL
$232.22 - $282.96 $10.8 Million - $13.2 Million
-46,575 Reduced 5.16%
855,383 $212 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $22.6 Million - $34.1 Million
-121,991 Reduced 11.91%
901,958 $238 Million
Q1 2020

May 15, 2020

BUY
$161.17 - $221.51 $3.38 Million - $4.65 Million
20,997 Added 2.09%
1,023,949 $194 Million
Q4 2019

Feb 14, 2020

SELL
$189.68 - $222.09 $7.08 Million - $8.29 Million
-37,343 Reduced 3.59%
1,002,952 $220 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $5.11 Million - $6.04 Million
-27,851 Reduced 2.61%
1,040,295 $204 Million
Q2 2019

Aug 14, 2019

SELL
$188.72 - $215.43 $16.2 Million - $18.4 Million
-85,604 Reduced 7.42%
1,068,146 $223 Million
Q1 2019

May 15, 2019

SELL
$136.09 - $200.44 $4.98 Million - $7.34 Million
-36,612 Reduced 3.08%
1,153,750 $229 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $2.59 Million - $3.97 Million
19,487 Added 1.66%
1,190,362 $172 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $17.8 Million - $24.7 Million
-120,802 Reduced 9.35%
1,170,875 $239 Million
Q2 2018

Aug 14, 2018

SELL
$144.9 - $165.58 $12.6 Million - $14.4 Million
-86,670 Reduced 6.29%
1,291,677 $191 Million
Q1 2018

May 15, 2018

SELL
$131.46 - $151.04 $7.39 Million - $8.49 Million
-56,210 Reduced 3.92%
1,378,347 $208 Million
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $1.2 Million - $1.34 Million
-9,923 Reduced 0.69%
1,434,557 $186 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $164 Million - $179 Million
1,444,480
1,444,480 $175 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.